MRC1 and cancer: Recently, anti-inflammatory macrophage-like (CD206+ MHC IIlow or negative), but not pro-inflammatory macrophage-like (CD206− MHCIIhi) TAMs have been reported to express PD1 in both a mouse model and in human cancers over time with disease progression (37).